Imitrex, Sumatriptan Wire
Comprehensive News Feed for Imitrex, Sumatriptan (generic).
Results 1 - 20 of 97 in Imitrex, Sumatriptan (generic)
-
Many people suffer from migraine headaches, including myself. Migraines tend to run in families and are more common in women then men. Comment?
-
What Are Cluster Headaches? What Causes Cluster Headaches?
Cluster headaches , also nicknamed suicide headaches, occur several times a day, they come on unexpectedly, do not last long, and are generally very painful. Comment?
-
I have used Maxalt for several years. It was the only medication that worked for me at the time that I was diagnosed . Comment?
-
New Information on the Triptans in Pregnancy
It is rare to do actual drug research on pregnant patients so it is always a boon when good research comes out that relates to pregnancy. Comment?
-
Migraine Term of the Day: Serotonin
w/Photo
When we're looking at Migraine and headache information, whether it's from our doctor, a book, or an online article, we sometimes come across medical terms that can be confusing. Comment?
-
I have SEVERE migraines since I was 8 years old...have tried everything except Botox and Accupunture. 1 comment
-
Suppression of Clinical Trials of Sumatriptan
Correspondence to the Lancet two weeks ago revealed another instance in which clinical research studies that failed to provide results favorable to a sponsor's product were suppressed. Comment?
-
Is Dr. Reddy's Laboratories Ready to Run?
While I've traded Dr. Reddy's Laboratories in the past, I have not touched it in the past few years; however as we await for the new Market Vectors Indian Small Cap fund to launch, I was poking my nose around Indian stocks this weekend since the Indian market has corrected quite a bit . Comment?
-
Dr Reddy's seeks US marketing rights for `Lipitor' generic
Integrated pharmaceuticals company Dr Reddy's Laboratories has filed for marketing rights to a generic version of Pfizer's cholesterol-lowering drug Lipitor, in the US, reports quoting company sources said. Comment?
-
New product launches, limited competition helped boost Par's Q3
WOODCLIFF LAKE, N.J. Generic drug maker Par Pharmaceutical had revenues of $294.8 million and profits of $26.3 million during third quarter 2009, the company announced in a financial report Friday. Comment?
-
At the onset of a migraine, the pain can be absolutely debilitating. Experiencing one can leave the senses vulnerable to light, to sound, to touch. Comment?
-
What do you BFing mommies take for migraines?
Last night, I had the mother of all migraines. It was horrible. I haven't had one that bad in years. Comment?
-
Pozen Inc. Reports Operating Results
Pozen Inc. filed Quarterly Report for the period ended 2009-09-30. Pozen Inc. is pharmaceutical development company committed to building a portfolio of products with significant commercial potential in select therapeutic areas. Comment?
-
Is there a Sure Fire Drug out there that stops migraines?
Is there a Sure Fire Drug out there that stops migraines? 10/30/09 sara Topics: Migraine Treatment I have suffered from migraines since I was 13. Comment?
-
Popular medicine in new form could get around nausea problem for migraine sufferers
PHILADELPHIA, PA.; October 29, 2009 -- The 30 million Americans who get migraines know they are more than just headaches. Comment?
-
Zogenix, Desitin Pharmaceuticals announce filing for European regulatory approval of SUMAVEL DosePro
The announcement follows successful completion of a European pivotal bioequivalence trial comparing needle-free SUMAVEL DosePro to a traditional needle-based autoinjector, Imigran-Inject, the European brand of Imitrex STATdose System. Comment?
-
Glaxo profit rose as currency gains o0ffset generics
Net income increased to 1.34 billion pounds from 1.03 billion pounds a year earlier, London-based Glaxo said in a Regulatory News Service statement today. Comment?
-
Zogenix and Desitin Announce Filing for European Regulatory Approval...
Zogenix, Inc., a privately held pharmaceutical company, and Desitin Pharmaceuticals GmbH , a privately held, mid-sized German pharmaceutical company, today announced that Desitin has filed for European regulatory approval of SUMAVEL DosePro needle-free delivery system. Comment?
-
Third-quarter fiscal 2009 results announced by POZEN
POZEN Inc. , today announced results for the third quarter ended September 30, 2009. Comment?
-
POZEN Reports Third Quarter 2009 Results
POZEN Inc. , today announced results for the third quarter ended September 30, 2009. Comment?
Imitrex, Sumatriptan Forum
Most Popular
- Tiger Woods Car Crash Update: After fight with wife he hit fire hydrant then ... - 495 comments
- AP Exclusive: Obama aunt anguished by separation - 143 comments
- How Can We Still Trust the Climate Scientists? - 164 comments
- Palin's "Homey" Bus Tour A Hoax: Report - 277 comments
- Swiss ban mosque minarets in surprise vote - 230 comments
- Rove Fires Back at Lauer Charge That Bush Administration 'Took Its Eye Off th... - 152 comments
- Jon Stewart on ClimateGate: 'Poor Al Gore - Global Warming Debunked Via Inter... - 142 comments
- Movement is under way in California to ban divorce - 86 comments
- Sharpton's daughter, ex threw profane tantrum at cops: att'y - 58 comments
- Obama Approval on Afghanistan, at 35%, Trails Other Issues - 112 comments
|
Reach local customers. Engage a specific demographic. Maximize business-to-business opportunities. Topix can deliver your message.
|
Copyright ©2009 Topix LLC
